{name}
{subtitle}
Doxorubicin Hydrochloride and Cyclophosphamide Followed by Paclitaxel With or Without Carboplatin in Treating Patients With Triple-Negative Breast Cancer
city
~32 mi. (Pittsfield, Massachusetts, +822 more cities)
facility
Berkshire Medical Center - Cancer Center
biomarker
ER Negative, +2 more biomarkers
drug
carboplatin, +3 more drugs
Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been or Will Be Removed by Surgery (The ALCHEMIST Screening Trial)
city
~32 mi. (Pittsfield, Massachusetts, +954 more cities)
facility
Berkshire Medical Center - Cancer Center
drug
crizotinib, +4 more drugs
drug type
chemotherapy, +2 more types
Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III-IV Classic Hodgkin Lymphoma
city
~42 mi. (Springfield, Massachusetts, +454 more cities)
facility
Baystate Medical Center
drug
brentuximab vedotin, +7 more drugs
drug type
chemotherapy, +3 more types
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
city
~42 mi. (Springfield, Massachusetts, +825 more cities)
facility
Baystate Medical Center
biomarker
AKT1 Mutation, +91 more biomarkers
condition
Breast Carcinoma, +3 more conditions
drug
adavosertib, +26 more drugs
drug type
immunotherapy, +1 more type
Testing the Addition of the Immunotherapy Drug Pembrolizumab to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) in Stage III-IV or Recurrent Endometrial Cancer
city
~42 mi. (Springfield, Massachusetts, +240 more cities)
facility
Baystate Medical Center
condition
Endometrial Adenocarcinoma, +5 more conditions
drug
carboplatin, +2 more drugs
drug type
chemotherapy, +1 more type